Physiologically‐Based Pharmacokinetic Modeling for Drug Dosing in Pediatric Patients: A Tutorial for a Pragmatic Approach in Clinical Care

JEM van der Heijden, JJM Freriksen… - Clinical …, 2023 - Wiley Online Library
It is well‐accepted that off‐label drug dosing recommendations for pediatric patients should
be based on the best available evidence. However, the available traditional evidence is …

Physiologically based pharmacokinetic modeling in neonates: Current status and future perspectives

W Zhang, Q Zhang, Z Cao, L Zheng, W Hu - Pharmaceutics, 2023 - mdpi.com
Rational drug use in special populations is a clinical problem that doctors and pharma-cists
must consider seriously. Neonates are the most physiologically immature and vulnerable to …

Synthesis of novel MOF-on-MOF composite as a magnetic sorbent to dispersive micro solid phase extraction of benzodiazepine drugs prior to determination with …

MOK Abad, M Masrournia, A Javid - Microchemical Journal, 2024 - Elsevier
Diazepam and lorazepam are two benzodiazepine drugs widely prescribed as
antidepressants and antiepileptics. A straightforward and time-save dispersive micro solid …

Expression of intestinal drug transporter proteins and metabolic enzymes in neonatal and pediatric patients

T de Waal, N Handin, J Brouwers, M Miserez… - International Journal of …, 2024 - Elsevier
The development of pediatric oral drugs is hampered by a lack of predictive simulation tools.
These tools, in turn, require data on the physiological variables that influence oral drug …

Physiologically‐based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population

EJ Thompson, A Jeong, VE Helfer… - CPT …, 2024 - Wiley Online Library
Pantoprazole is a proton pump inhibitor indicated for the treatment of gastroesophageal
reflux disease, a condition that disproportionately affects children with obesity. Appropriately …

Getting the dose right using physiologically-based pharmacokinetic modeling: dexamethasone to prevent post-extubation stridor in children as proof of concept

JEM van der Heijden, M de Hoop-Sommen… - Frontiers in …, 2024 - frontiersin.org
Introduction Critically ill patients show large variability in drug disposition due to eg, age,
size, disease and treatment modalities. Physiologically-based pharmacokinetic (PBPK) …

Pragmatic physiologically-based pharmacokinetic modeling to support clinical implementation of optimized gentamicin dosing in term neonates and infants: proof-of …

MA de Hoop-Sommen, JEM van der Heijden… - Frontiers in …, 2023 - frontiersin.org
Introduction Modeling and simulation can support dosing recommendations for clinical
practice, but a simple framework is missing. In this proof-of-concept study, we aimed to …

Towards More Robust Evaluation of the Predictive Performance of Physiologically Based Pharmacokinetic Models: Using Confidence Intervals to Support Use of …

MD van Borselen, LAÆ Sluijterman, R Greupink… - Clinical …, 2024 - Springer
Abstract Background and Objective With the rise in the use of physiologically based
pharmacokinetic (PBPK) modeling over the past decade, the use of PBPK modeling to …

Optimization of the betamethasone and dexamethasone dosing regimen during pregnancy: a combined placenta perfusion and pregnancy physiologically based …

JEM Van Der Heijden, H Van Hove, NM Van Elst… - American Journal of …, 2024 - Elsevier
Background Antenatal betamethasone and dexamethasone are prescribed to women who
are at high risk of premature birth to prevent neonatal respiratory distress syndrome (RDS) …

Virtual Clinical Trials Guided Design of an Age-Appropriate Formulation and Dosing Strategy of Nifedipine for Paediatric Use

D Khan, R Badhan, DJ Kirby, S Bryson, M Shah… - Pharmaceutics, 2023 - mdpi.com
The rapid onset of action of nifedipine causes a precipitous reduction in blood pressure
leading to adverse effects associated with reflex sympathetic nervous system (SNS) …